How to manage a patient with a history of substance abuse, currently on suboxone (buprenorphine) 2mg, with chronic sleep issues, who has tried various medications including Ambien (zolpidem), BelSomra (suvorexant), Quvivq, trazodone, mirtazapine, doxepin, hydroxyzine, and clonidine, and is now requesting an increased dose of temazepam to 75mg after finding 30mg effective?

Managing Escalating Benzodiazepine Dependence in a Patient with Substance Use History

You must stop escalating temazepam immediately and transition this patient to a non-addictive sleep medication regimen combined with intensive CBT-I, as he is demonstrating classic benzodiazepine tolerance and dose escalation despite his recovery from opioid use disorder. 1

Critical Safety Concerns

This patient is exhibiting dangerous patterns that require immediate intervention:

• Benzodiazepine tolerance and dose escalation: Requesting 75mg temazepam (2.5x the maximum recommended dose of 30mg) after already taking 60mg nightly represents clear tolerance development and potential substance use disorder transfer 1, 2
• Polypharmacy risk: Previously combining lorazepam 2mg + hydroxyzine 50mg + ambien represents dangerous CNS depressant stacking with increased risks of respiratory depression, falls, and cognitive impairment 1
• Substance use vulnerability: His history of opioid use for sleep and current suboxone treatment indicates high risk for developing benzodiazepine use disorder 3

The American Academy of Sleep Medicine explicitly warns against benzodiazepines as first-line treatment and recommends avoiding them entirely in patients with substance use history. 1

Immediate Action Plan

Step 1: Do NOT Increase Temazepam Dose

• Refuse the request for 75mg temazepam - this dose exceeds safety limits and reinforces addiction patterns 1, 2
• Explain to the patient that dose escalation indicates tolerance, not treatment failure, and that continuing this path leads to dependence 3
• Frame this as protecting his recovery, not denying treatment 1

Step 2: Initiate or Intensify CBT-I Immediately

CBT-I must be the foundation of treatment before any medication adjustments. 4, 1

The American College of Physicians and American Academy of Sleep Medicine recommend CBT-I as first-line treatment with superior long-term efficacy compared to medications:

• Stimulus control therapy: Go to bed only when sleepy, use bed only for sleep/sex, leave bedroom if not asleep within 20 minutes 1
• Sleep restriction therapy: Limit time in bed to actual sleep time plus 30 minutes, gradually increase as sleep efficiency improves 1
• Cognitive restructuring: Address catastrophic thinking about sleep consequences 1
• Sleep hygiene optimization: Consistent wake time, avoid caffeine after 2pm, no alcohol, regular exercise (not within 3 hours of bedtime) 1

CBT-I can be delivered via individual therapy, group sessions, telephone-based programs, or web-based modules - all showing effectiveness 1

Step 3: Transition to Non-Addictive Pharmacotherapy

For patients with substance use history, ramelteon is the ONLY appropriate first-line choice due to zero abuse potential and non-DEA-scheduled status. 1

Primary Recommendation: Ramelteon 8mg

• Ramelteon 8mg at bedtime is specifically recommended for patients with substance use history 1
• Zero addiction potential, no tolerance development, no withdrawal syndrome 1
• Targets sleep onset through melatonin receptor agonism 1
• Can be used long-term without dependence risk 1

Secondary Option: Low-Dose Doxepin 3-6mg

If sleep maintenance (not onset) is the primary issue, low-dose doxepin 3-6mg is the evidence-based choice. 1, 5

• Reduces wake after sleep onset by 22-23 minutes 5
• No abuse potential, no tolerance development 5
• Minimal anticholinergic effects at low doses (3-6mg vs 25-150mg for depression) 5
• Take 30 minutes before bedtime on empty stomach 5
• NOT effective for sleep onset - only for sleep maintenance 5

Step 4: Taper Temazepam Safely

Abrupt discontinuation of benzodiazepines causes dangerous withdrawal including seizures, rebound insomnia, and anxiety. 3

Tapering protocol while starting ramelteon:

• Week 1-2: Start ramelteon 8mg + continue temazepam 30mg (reduce from 60mg to 30mg)
• Week 3-4: Ramelteon 8mg + temazepam 22.5mg
• Week 5-6: Ramelteon 8mg + temazepam 15mg
• Week 7-8: Ramelteon 8mg + temazepam 7.5mg
• Week 9+: Ramelteon 8mg alone

Monitor closely for withdrawal symptoms: anxiety, tremor, sweating, insomnia rebound, seizures 3

What NOT to Do

Medications to Absolutely Avoid

• Trazodone: American Academy of Sleep Medicine explicitly recommends AGAINST trazodone for insomnia - insufficient efficacy data, harms outweigh benefits 1
• Additional benzodiazepines: No lorazepam, clonazepam, or other benzodiazepines - all carry high abuse potential in this patient 1
• Z-drugs (zolpidem, eszopiclone): While safer than benzodiazepines, still carry abuse potential and should be avoided given his substance use history 1
• Quetiapine or other antipsychotics: Explicitly warned against by American Academy of Sleep Medicine due to metabolic side effects and lack of efficacy evidence 1
• Over-the-counter antihistamines: Not recommended due to lack of efficacy data, anticholinergic burden, and tolerance after 3-4 days 1

Addressing Patient Resistance

This patient will likely resist this plan because benzodiazepines provide immediate sedation he's become dependent on. Key counseling points:

• Acknowledge his struggle: "I understand you're desperate for sleep and the temazepam has been working, but the fact you need more and more tells us your body is becoming dependent" 3
• Connect to his recovery: "You've done incredible work getting off opioids and down to 2mg suboxone. Benzodiazepines work on similar brain pathways and we don't want to trade one dependence for another" 3
• Set realistic expectations: "Ramelteon won't knock you out like temazepam, but it will help your natural sleep system recover. Combined with CBT-I, this provides lasting improvement, not just temporary sedation" 1
• Emphasize safety: "At 75mg temazepam, you're at serious risk for falls, cognitive impairment, and respiratory depression, especially combined with suboxone" 1

Monitoring and Follow-Up

• Weekly visits during taper to assess withdrawal symptoms, sleep quality, and medication adherence 1
• Sleep diary documentation throughout transition to track objective sleep parameters 1
• Screen for complex sleep behaviors with ramelteon (though rare compared to benzodiazepines) 1
• Coordinate with addiction medicine if he has a suboxone prescriber - they should be aware of benzodiazepine dependence 3
• Reassess after 4-6 weeks on ramelteon + CBT-I to evaluate efficacy 1

Long-Term Strategy

The goal is medication-free sleep or minimal ramelteon use with robust CBT-I skills. 4, 1

• CBT-I provides sustained benefits after discontinuation, unlike medications 4
• Ramelteon can be used long-term if needed without tolerance or dependence 1
• Consider sleep study if insomnia persists despite optimal treatment - may have undiagnosed sleep apnea or other sleep disorder 4

This patient's request for 75mg temazepam is a red flag for substance use disorder transfer that requires firm boundaries and evidence-based intervention, not accommodation. 1, 3